 |
Musolino Antonino; Campone Mario; Neven Patrick; Denduluri Neelima; Barrios Carlos H; Cortes Javier; Blackwell Kimberly; Soliman Hatem; Kahán Zsuzsanna; Bonnefoi Herve; Squires Matthew; Zhang Yong; Deudon Stephanie; Shi Michael M; Andre Fabrice:
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2(-) breast cancer that had progressed during or after prior endocrine therapy.
BREAST CANCER RESEARCH, 19.
ISSN 1465-5411
(2017)
Vrdoljak Eduard; Marschner N.; Zielinski Christoph Carl; Gligorov Joseph; Cortes Javier; Puglisi Fabio; Aapro Matti S.; Fallowfield Lesley J.; Fontana Andrea; Inbar Moshe Josef; Kahán Zsuzsanna; Welt Anja; Lévy Christelle; Brain Étienne G.C.; Pivot Xavier B.:
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.
ANNALS OF ONCOLOGY, 27 (11).
pp. 2046-2052.
ISSN 0923-7534
(2016)
![[Fel]](/style/images/multi_up.png)
Vissza
